Recipients of the Pfizer Psychiatry Research Awards Program

Below are the recipients of the Pfizer Psychiatry Research Awards. On behalf of Pfizer Canada and the review committee, congratulations to all recipients!


Recipients

Tabs: 

For the first competition (Round 1), a total of 12 proposals were received. All proposals underwent a preliminary review by Pfizer Canada Medical to ensure they met eligibility criteria posted on the website. On 20 January 2012, eligible proposals were reviewed and rated using a rigorous process by an independent review committee composed of 12 Canadian experts in psychiatry. This resulted in 2 awardees being selected, based on best total scores.

On behalf of the review committee, the committee chair Dr. Glenda MacQueen, and Pfizer Canada Inc., it is our pleasure to announce the awardees:

Pfizer Canada Major Depressive Disorders Research Award (grant) :
Dr. Elizabeth Osuch
University of Western Ontario
Functional Neuroimaging of intrinsic hemodynamic networks in bipolar disorder and unipolar depressive disorder

Pfizer Canada Schizophrenia or Bipolar Disorder Research Award (grant) :
Dr. Jehannine Austin
University of British-Columbia
Effect of genetic counseling on adherence to psychotropic medication in serious mental illness

For the second competition (Round 2), a total of 9 proposals were received. All proposals underwent a preliminary review by Pfizer Canada Medical to ensure they met eligibility criteria posted on the website. On 18 January 2013, eligible proposals were reviewed and rated using a rigorous process by an independent review committee composed of 12 Canadian experts in psychiatry. This resulted in 2 awardees being selected, based on best total scores.

On behalf of the review committee, the committee chair Dr. Glenda MacQueen, and Pfizer Canada Inc., it is our pleasure to announce the awardees:

Pfizer Canada Major Depressive Disorders Research Award (grant):
Dr. Rajamannar Ramasubbu
University of Calgary
Prediction of Individual Treatment Response Based on Brain Changes at the Early Phase of Antidepressant Treatment

Pfizer Canada Schizophrenia or Bipolar Disorder Research Award (grant) :
Dr. Jorge Armony
McGill University
Emotional and Cognitive Control in Bipolar Disorder Type I

For the third competition (Round 3), a total of 10 proposals were received. All proposals underwent a preliminary review by Pfizer Canada Medical to ensure they met eligibility criteria posted on the website. On 17 January 2014, eligible proposals were reviewed and rated using a rigorous process by an independent review committee composed of 12 Canadian experts in psychiatry. This resulted in 3 awardees being selected, based on best total scores.

On behalf of the review committee, the committee chair Dr. Glenda MacQueen, and Pfizer Canada Inc., it is our pleasure to announce the awardees:

Pfizer Canada Major Depressive Disorders Research Award (grant):
Dr. Didier Jutras-Aswad
Centre Hospitalier de l'Université de Montréal
An Open-Label Pilot Study of Desvenlafaxine for Opioid-Dependent Patients With Comorbid Depression

Pfizer Canada Geriatric Anxiety Research Award (Grant)
No awardee selected by the review committee

Healthy Minds Canada/Sun Life Financial/Pfizer Canada Research Award (Grant)
Dr. Christopher Bowie
Queen's University
Action-Based Cognitive Remediation to Improve Vocational Outcomes in Depression

Hotchkiss Brain Institute/Pfizer Canada Research Award (Grant)
Dr. Vina Goghari
Hotchkiss Brain Institute, University of Calgary
Potential Cell Membrane Biomarkers in Prefrontal White Matter and Erythrocytes in Euthymic Bipolar Disorder I

Institut Universitaire en Santé Mentale de Montréal/Pfizer Canada Research Award (Grant)
No awardee selected by the review committee

For the fourth competition (Round 4), a total of 12 proposals were received. All proposals underwent a preliminary review by Pfizer Canada Medical to ensure they met eligibility criteria posted on the website. On 16 January 2015, eligible proposals were reviewed and rated using a rigorous process by an independent review committee composed of Canadian experts in psychiatry. This resulted in 3 awardees being selected, based on best total scores.

On behalf of the review committee, the committee chair Dr. Glenda MacQueen, and Pfizer Canada Inc., it is our pleasure to announce the awardees:

Pfizer Canada Major Depressive Disorders Research Award (grant):
Dr. Gustavo Turecki
McGill University
miRNAs as Reliable Predictors of Antidepressant Response

Healthy Minds Canada/Pfizer Canada Research Award (Grant)
Dr. Tania Lecomte
Université de Montréal
Preventing depression relapse and improving well-being at work

Hotchkiss Brain Institute/Pfizer Canada Research Award (Grant)
Dr. Scott Patten
Hotchkiss Brain Institute, University of Calgary
Development of an eHub for Mental Health in Epilepsy

Institut Universitaire en Santé Mentale de Montréal/Pfizer Canada Research Award (Grant)
No awardee selected by the review committee

For the fifth competition (Round 5), a total of 17 proposals were received. All proposals underwent a preliminary review by Pfizer Canada Medical to ensure they met eligibility criteria posted on the website. On 15 January 2016, eligible proposals were reviewed and rated using a rigorous process by an independent review committee composed of Canadian experts in psychiatry. This resulted in 3 awardees being selected, based on best total scores.

On behalf of the review committee, the committee chair Dr. Glenda MacQueen, and Pfizer Canada Inc., it is our pleasure to announce the awardees:

Pfizer Canada Major Depressive Disorders Research Award (grant):
Dr. Sakina Rizvi
St.Michael’s Hospital, Toronto
A dimensional approach to evaluate reward processing in major depressive disorder before and after treatment with desvenlafaxine

Healthy Minds Canada/Pfizer Canada Research Award (Grant)
Dr. Norbert Schmitz
McGill University
Depression and Anxiety as Risk Factors for Type 2 Diabetes: The Role of Systemic Inflammation

Hotchkiss Brain Institute/Pfizer Canada Research Award (Grant)
Dr. JianLi Wang
Hotchkiss Brain Institute, University of Calgary
Sex/age differences in preferred design features of e-mental health program